FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3008720661> ?p ?o ?g. }

• W3008720661 endingPage "343.e3" @default.
• W3008720661 startingPage "332" @default.
• W3008720661 abstract "Background Cells detaching from the primary tumor site are metastasis initiator cells, and the detection of CTC, known as liquid biopsy, is an important test of biomarkers of cancer progression. We investigated the molecular characterization of circulating tumor cells (CTCs), profiled the plasma microRNA (miR) content, and analyzed the relationship with the clinical outcomes by sampling the peripheral blood from patients with locally advanced breast cancer before and after neoadjuvant chemotherapy. Patients and Methods Markers of breast cancer, epithelial–mesenchymal transition (EMT), drug resistance, and stem cells were used for CTC isolation and characterization. Plasma miR profiles were obtained from selected patients with CTC positivity determined using next-generation sequencing. Results The proportion of CTC, EMT, and stem cell marker positivity was 16.7%, 8.3%, and 25% before and 18.2%, 15.2%, and 9.1% after treatment, respectively. A significant correlation was found between the pretreatment CTCs and ALDH1 positivity (P = .0245). These CTCs with stemness properties were observed in most hormone receptor–positive, human epidermal growth factor receptor 2–negative cases and were also present with a high incidence in cases of early metastasis. miR-146b-5p and miR-199a-5p, which are involved in metastasis, invasion, and EMT, were accompanied by CTC positivity, and miR-4646-3p was associated with the development of early metastasis. Conclusions Molecular characterization of CTCs and miR profiling of serial samples from patients with locally advanced breast cancer during neoadjuvant chemotherapy appears to be a very useful in predicting cure and clinical course and might be a key to developing new targeted therapies." @default.
• W3008720661 created "2020-03-06" @default.
• W3008720661 creator A5005202578 @default.
• W3008720661 creator A5008111986 @default.
• W3008720661 creator A5012400941 @default.
• W3008720661 creator A5039717404 @default.
• W3008720661 creator A5047208027 @default.
• W3008720661 creator A5049810133 @default.
• W3008720661 creator A5051798949 @default.
• W3008720661 creator A5053589467 @default.
• W3008720661 creator A5056628552 @default.
• W3008720661 creator A5068542394 @default.
• W3008720661 creator A5074451669 @default.
• W3008720661 creator A5089580824 @default.
• W3008720661 date "2020-08-01" @default.
• W3008720661 modified "2023-10-18" @default.
• W3008720661 title "Response Assessment With Molecular Characterization of Circulating Tumor Cells and Plasma MicroRNA Profiling in Patients With Locally Advanced Breast Cancer During Neoadjuvant Chemotherapy" @default.
• W3008720661 cites W1930449581 @default.
• W3008720661 cites W1944188907 @default.
• W3008720661 cites W1973816122 @default.
• W3008720661 cites W1993497779 @default.
• W3008720661 cites W1994220056 @default.
• W3008720661 cites W2021880506 @default.
• W3008720661 cites W2027541642 @default.
• W3008720661 cites W2032227988 @default.
• W3008720661 cites W2034819890 @default.
• W3008720661 cites W2036169252 @default.
• W3008720661 cites W2050434028 @default.
• W3008720661 cites W2051742304 @default.
• W3008720661 cites W2052421497 @default.
• W3008720661 cites W2052785172 @default.
• W3008720661 cites W2058935670 @default.
• W3008720661 cites W2068705679 @default.
• W3008720661 cites W2075060873 @default.
• W3008720661 cites W2075894019 @default.
• W3008720661 cites W2082239705 @default.
• W3008720661 cites W2095259408 @default.
• W3008720661 cites W2106181914 @default.
• W3008720661 cites W2111976640 @default.
• W3008720661 cites W2114397636 @default.
• W3008720661 cites W2123591186 @default.
• W3008720661 cites W2128340149 @default.
• W3008720661 cites W2140028276 @default.
• W3008720661 cites W2145795890 @default.
• W3008720661 cites W2146495977 @default.
• W3008720661 cites W2147054592 @default.
• W3008720661 cites W2147415463 @default.
• W3008720661 cites W2159431488 @default.
• W3008720661 cites W2160918828 @default.
• W3008720661 cites W2164774797 @default.
• W3008720661 cites W2169456326 @default.
• W3008720661 cites W2169632044 @default.
• W3008720661 cites W2234979117 @default.
• W3008720661 cites W2340725433 @default.
• W3008720661 cites W2350123421 @default.
• W3008720661 cites W2517040293 @default.
• W3008720661 cites W2530460077 @default.
• W3008720661 cites W2538686606 @default.
• W3008720661 cites W2552558017 @default.
• W3008720661 cites W2562530427 @default.
• W3008720661 cites W2791202068 @default.
• W3008720661 cites W2796752297 @default.
• W3008720661 cites W2864447112 @default.
• W3008720661 cites W2899522607 @default.
• W3008720661 cites W2902539135 @default.
• W3008720661 doi "https://doi.org/10.1016/j.clbc.2020.02.006" @default.
• W3008720661 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32201164" @default.
• W3008720661 hasPublicationYear "2020" @default.
• W3008720661 type Work @default.
• W3008720661 sameAs 3008720661 @default.
• W3008720661 citedByCount "5" @default.
• W3008720661 countsByYear W30087206612020 @default.
• W3008720661 countsByYear W30087206612021 @default.
• W3008720661 countsByYear W30087206612022 @default.
• W3008720661 countsByYear W30087206612023 @default.
• W3008720661 crossrefType "journal-article" @default.
• W3008720661 hasAuthorship W3008720661A5005202578 @default.
• W3008720661 hasAuthorship W3008720661A5008111986 @default.
• W3008720661 hasAuthorship W3008720661A5012400941 @default.
• W3008720661 hasAuthorship W3008720661A5039717404 @default.
• W3008720661 hasAuthorship W3008720661A5047208027 @default.
• W3008720661 hasAuthorship W3008720661A5049810133 @default.
• W3008720661 hasAuthorship W3008720661A5051798949 @default.
• W3008720661 hasAuthorship W3008720661A5053589467 @default.
• W3008720661 hasAuthorship W3008720661A5056628552 @default.
• W3008720661 hasAuthorship W3008720661A5068542394 @default.
• W3008720661 hasAuthorship W3008720661A5074451669 @default.
• W3008720661 hasAuthorship W3008720661A5089580824 @default.
• W3008720661 hasConcept C121608353 @default.
• W3008720661 hasConcept C126322002 @default.
• W3008720661 hasConcept C142724271 @default.
• W3008720661 hasConcept C143998085 @default.
• W3008720661 hasConcept C2775930923 @default.
• W3008720661 hasConcept C2776694085 @default.
• W3008720661 hasConcept C2779013556 @default.
• W3008720661 hasConcept C2779529041 @default.
• W3008720661 hasConcept C502942594 @default.
• W3008720661 hasConcept C530470458 @default.

• next